Form S-1/A Virpax Pharmaceuticals,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Virpax Pharmaceuticals (VRPX) Files for 16.85M Share and Warrant Offering
January 15, 2025 4:35 PM ESTVirpax Pharmaceuticals (NASDAQ: VRPX) has filed the following:
We are offering on a best efforts basis up to 16,849,200 shares of our Common Stock, par value $0.00001 per share (the Common Stock).
We are also offering to each purchaser, if any, whose purchase of shares of Common Stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties,... More
